Report

  1. Home
  2. Discounted reports

Consumer Healthcare Market By Product (OTC Pharmaceuticals, Personal Care Products, Dietary Supplements), By Distribution Channel (Online, Offline): Global Opportunity Analysis and Industry Forecast, 2023-2032

Market Report I 2023-05-01 I 270 Pages I Allied Market Research
Discounted by 10% to 2024-11-15

The global consumer healthcare market was valued at $280.1 billion in 2022, and is projected to reach $574.4 billion by 2032, growing at a CAGR of 7.5% from 2023 to 2032.Consumer healthcare products includes the non-prescription drugs such as analgesics, antacids, skin care products, nutraceuticals, and personal hygiene products. In addition, consumer healthcare products also include oral care products and cosmetics that are used to treat any kind of skin or hair disease conditions.
The growth of the consumer healthcare market is driven by surge in demand of skin care products, increase in trend of self-buying healthcare products, and rise in access to the healthcare literatures. Moreover, large consumer healthcare products firms all over the world increasingly focus on acquiring companies that provide best consumer healthcare products, which is expected to notably contribute toward the market growth. For instance, in April 2023, WellSpring Consumer Healthcare, a developer and marketer of leading over-the-counter and personal care brands, announced the acquisition of Iconic OTC Skin Care, a portfolio of well-recognized and trusted over-the-counter (OTC) skin care brands from Bayer AG.
Furthermore, the global consumer healthcare market growth is largely driven by factors such as significant rise in demand of vitamins and minerals by people in post pandemic situation to maintain their physical health, and various initiatives by manufacturing companies to promote their consumer healthcare products, and the increase in trend of buying online products. Prominent players in the global consumer healthcare market have opted various strategies such as product launches, acquisition, and investments in R&D for development of customized consumer centric healthcare products to strengthen their position in the market and sustain the competitive environment.
An alarming increase in prevalence of infectious diseases and skin diseases across the globe is one of the key factors that drive the growth of the market. However, the stringent government regulations and misuse of consumer healthcare products restrict the market growth. Conversely, the increase in demand for nutraceuticals and the awareness about personal health, especially among patients in emerging nations, are expected to provide lucrative opportunities for the growth of the market in the near future. Extensive R&D activities in the field of consumer healthcare along with significant improvement in healthcare infrastructure are anticipated to open new avenues for the expansion of the market.
The consumer healthcare market is segmented on the basis of product, distribution channel, and region. On the basis of product, the market is categorized into OTC pharmaceuticals, personal care products and dietary supplements. On the basis of distribution channel, the market is classified into online and offline. The offline segment is further classified into supermarkets and hypermarkets, pharmacies, and others. On the basis of region, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major companies profiled in the report include Johnson & Johnson, Sanofi, Pfizer Inc., Abbott Laboratories, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Bayer AG, Amway, and BASF SE.
Key Benefits For Stakeholders
-This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the consumer healthcare market analysis from 2022 to 2032 to identify the prevailing consumer healthcare market opportunities.
-The market research is offered along with information related to key drivers, restraints, and opportunities.
-Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
-In-depth analysis of the consumer healthcare market segmentation assists to determine the prevailing market opportunities.
-Major countries in each region are mapped according to their revenue contribution to the global market.
-Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
-The report includes the analysis of the regional as well as global consumer healthcare market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
- OTC Pharmaceuticals
- Personal Care Products
- Dietary Supplements
By Distribution Channel
- Online
- Offline
- Type
- Supermarkets and Hypermarkets
- Pharmacies
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- GlaxoSmithKline plc
- Sanofi S.A.
- BASF SE
- Johnson & Johnson
- Pfizer Inc.
- BOEHRINGER INGELHEIM INTERNATIONAL GMBH
- Amway Corp.
- Teva Pharmaceutical Industries Limited
- Bayer AG
- Abbott Laboratories

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter's five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in consumers' desire to control their health
3.4.1.2. Digitization of consumer healthcare business
3.4.1.3. Rise in awareness about personal healthcare and increase in geriatric population

3.4.2. Restraints
3.4.2.1. The stringent government regulations

3.4.3. Opportunities
3.4.3.1. Latest startups in consumer healthcare market and development of customized products

3.5. COVID-19 Impact Analysis on the market
3.6. Average Selling Price
CHAPTER 4: CONSUMER HEALTHCARE MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. OTC Pharmaceuticals
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Personal Care Products
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Dietary Supplements
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL
5.1. Overview
5.1.1. Market size and forecast
5.2. Online
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Offline
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.3.4. Offline Consumer Healthcare Market by Type
CHAPTER 6: CONSUMER HEALTHCARE MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast By Region
6.2. North America
6.2.1. Key trends and opportunities
6.2.2. Market size and forecast, by Product
6.2.3. Market size and forecast, by Distribution Channel
6.2.4. Market size and forecast, by country
6.2.4.1. U.S.
6.2.4.1.1. Key market trends, growth factors and opportunities
6.2.4.1.2. Market size and forecast, by Product
6.2.4.1.3. Market size and forecast, by Distribution Channel
6.2.4.2. Canada
6.2.4.2.1. Key market trends, growth factors and opportunities
6.2.4.2.2. Market size and forecast, by Product
6.2.4.2.3. Market size and forecast, by Distribution Channel
6.2.4.3. Mexico
6.2.4.3.1. Key market trends, growth factors and opportunities
6.2.4.3.2. Market size and forecast, by Product
6.2.4.3.3. Market size and forecast, by Distribution Channel
6.3. Europe
6.3.1. Key trends and opportunities
6.3.2. Market size and forecast, by Product
6.3.3. Market size and forecast, by Distribution Channel
6.3.4. Market size and forecast, by country
6.3.4.1. Germany
6.3.4.1.1. Key market trends, growth factors and opportunities
6.3.4.1.2. Market size and forecast, by Product
6.3.4.1.3. Market size and forecast, by Distribution Channel
6.3.4.2. France
6.3.4.2.1. Key market trends, growth factors and opportunities
6.3.4.2.2. Market size and forecast, by Product
6.3.4.2.3. Market size and forecast, by Distribution Channel
6.3.4.3. UK
6.3.4.3.1. Key market trends, growth factors and opportunities
6.3.4.3.2. Market size and forecast, by Product
6.3.4.3.3. Market size and forecast, by Distribution Channel
6.3.4.4. Italy
6.3.4.4.1. Key market trends, growth factors and opportunities
6.3.4.4.2. Market size and forecast, by Product
6.3.4.4.3. Market size and forecast, by Distribution Channel
6.3.4.5. Spain
6.3.4.5.1. Key market trends, growth factors and opportunities
6.3.4.5.2. Market size and forecast, by Product
6.3.4.5.3. Market size and forecast, by Distribution Channel
6.3.4.6. Rest of Europe
6.3.4.6.1. Key market trends, growth factors and opportunities
6.3.4.6.2. Market size and forecast, by Product
6.3.4.6.3. Market size and forecast, by Distribution Channel
6.4. Asia-Pacific
6.4.1. Key trends and opportunities
6.4.2. Market size and forecast, by Product
6.4.3. Market size and forecast, by Distribution Channel
6.4.4. Market size and forecast, by country
6.4.4.1. China
6.4.4.1.1. Key market trends, growth factors and opportunities
6.4.4.1.2. Market size and forecast, by Product
6.4.4.1.3. Market size and forecast, by Distribution Channel
6.4.4.2. Japan
6.4.4.2.1. Key market trends, growth factors and opportunities
6.4.4.2.2. Market size and forecast, by Product
6.4.4.2.3. Market size and forecast, by Distribution Channel
6.4.4.3. India
6.4.4.3.1. Key market trends, growth factors and opportunities
6.4.4.3.2. Market size and forecast, by Product
6.4.4.3.3. Market size and forecast, by Distribution Channel
6.4.4.4. Australia
6.4.4.4.1. Key market trends, growth factors and opportunities
6.4.4.4.2. Market size and forecast, by Product
6.4.4.4.3. Market size and forecast, by Distribution Channel
6.4.4.5. South Korea
6.4.4.5.1. Key market trends, growth factors and opportunities
6.4.4.5.2. Market size and forecast, by Product
6.4.4.5.3. Market size and forecast, by Distribution Channel
6.4.4.6. Rest of Asia-Pacific
6.4.4.6.1. Key market trends, growth factors and opportunities
6.4.4.6.2. Market size and forecast, by Product
6.4.4.6.3. Market size and forecast, by Distribution Channel
6.5. LAMEA
6.5.1. Key trends and opportunities
6.5.2. Market size and forecast, by Product
6.5.3. Market size and forecast, by Distribution Channel
6.5.4. Market size and forecast, by country
6.5.4.1. Brazil
6.5.4.1.1. Key market trends, growth factors and opportunities
6.5.4.1.2. Market size and forecast, by Product
6.5.4.1.3. Market size and forecast, by Distribution Channel
6.5.4.2. Saudi Arabia
6.5.4.2.1. Key market trends, growth factors and opportunities
6.5.4.2.2. Market size and forecast, by Product
6.5.4.2.3. Market size and forecast, by Distribution Channel
6.5.4.3. South Africa
6.5.4.3.1. Key market trends, growth factors and opportunities
6.5.4.3.2. Market size and forecast, by Product
6.5.4.3.3. Market size and forecast, by Distribution Channel
6.5.4.4. Rest of LAMEA
6.5.4.4.1. Key market trends, growth factors and opportunities
6.5.4.4.2. Market size and forecast, by Product
6.5.4.4.3. Market size and forecast, by Distribution Channel
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2022
CHAPTER 8: COMPANY PROFILES
8.1. Johnson & Johnson
8.1.1. Company overview
8.1.2. Key Executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. Sanofi S.A.
8.2.1. Company overview
8.2.2. Key Executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business performance
8.3. Pfizer Inc.
8.3.1. Company overview
8.3.2. Key Executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Business performance
8.4. Abbott Laboratories
8.4.1. Company overview
8.4.2. Key Executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business performance
8.5. GlaxoSmithKline plc
8.5.1. Company overview
8.5.2. Key Executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.5.6. Business performance
8.5.7. Key strategic moves and developments
8.6. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
8.6.1. Company overview
8.6.2. Key Executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.7. Teva Pharmaceutical Industries Limited
8.7.1. Company overview
8.7.2. Key Executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. Business performance
8.8. Amway Corp.
8.8.1. Company overview
8.8.2. Key Executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.9. Bayer AG
8.9.1. Company overview
8.9.2. Key Executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.9.6. Business performance
8.10. BASF SE
8.10.1. Company overview
8.10.2. Key Executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
8.10.6. Business performance

LIST OF TABLES
TABLE 01. GLOBAL CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 02. CONSUMER HEALTHCARE MARKET FOR OTC PHARMACEUTICALS, BY REGION, 2022-2032 ($MILLION)
TABLE 03. CONSUMER HEALTHCARE MARKET FOR PERSONAL CARE PRODUCTS, BY REGION, 2022-2032 ($MILLION)
TABLE 04. CONSUMER HEALTHCARE MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2022-2032 ($MILLION)
TABLE 05. GLOBAL CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 06. CONSUMER HEALTHCARE MARKET FOR ONLINE, BY REGION, 2022-2032 ($MILLION)
TABLE 07. CONSUMER HEALTHCARE MARKET FOR OFFLINE, BY REGION, 2022-2032 ($MILLION)
TABLE 08. GLOBAL OFFLINE CONSUMER HEALTHCARE MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 09. CONSUMER HEALTHCARE MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 10. NORTH AMERICA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 11. NORTH AMERICA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 12. NORTH AMERICA CONSUMER HEALTHCARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 13. U.S. CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 14. U.S. CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 15. CANADA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 16. CANADA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 17. MEXICO CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 18. MEXICO CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 19. EUROPE CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 20. EUROPE CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 21. EUROPE CONSUMER HEALTHCARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 22. GERMANY CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 23. GERMANY CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 24. FRANCE CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 25. FRANCE CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 26. UK CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 27. UK CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 28. ITALY CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 29. ITALY CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 30. SPAIN CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 31. SPAIN CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 32. REST OF EUROPE CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 33. REST OF EUROPE CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 34. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 35. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 36. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 37. CHINA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 38. CHINA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 39. JAPAN CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 40. JAPAN CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 41. INDIA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 42. INDIA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 43. AUSTRALIA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 44. AUSTRALIA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 45. SOUTH KOREA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 46. SOUTH KOREA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 47. REST OF ASIA-PACIFIC CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 48. REST OF ASIA-PACIFIC CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 49. LAMEA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 50. LAMEA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 51. LAMEA CONSUMER HEALTHCARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 52. BRAZIL CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 53. BRAZIL CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 54. SAUDI ARABIA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 55. SAUDI ARABIA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 56. SOUTH AFRICA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 57. SOUTH AFRICA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 58. REST OF LAMEA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 59. REST OF LAMEA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 60. JOHNSON & JOHNSON: KEY EXECUTIVES
TABLE 61. JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 62. JOHNSON & JOHNSON: PRODUCT SEGMENTS
TABLE 63. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
TABLE 64. JOHNSON & JOHNSON: KEY STRATERGIES
TABLE 65. SANOFI S.A.: KEY EXECUTIVES
TABLE 66. SANOFI S.A.: COMPANY SNAPSHOT
TABLE 67. SANOFI S.A.: PRODUCT SEGMENTS
TABLE 68. SANOFI S.A.: PRODUCT PORTFOLIO
TABLE 69. PFIZER INC.: KEY EXECUTIVES
TABLE 70. PFIZER INC.: COMPANY SNAPSHOT
TABLE 71. PFIZER INC.: PRODUCT SEGMENTS
TABLE 72. PFIZER INC.: PRODUCT PORTFOLIO
TABLE 73. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 74. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 75. ABBOTT LABORATORIES: PRODUCT SEGMENTS
TABLE 76. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 77. GLAXOSMITHKLINE PLC: KEY EXECUTIVES
TABLE 78. GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT
TABLE 79. GLAXOSMITHKLINE PLC: PRODUCT SEGMENTS
TABLE 80. GLAXOSMITHKLINE PLC: PRODUCT PORTFOLIO
TABLE 81. GLAXOSMITHKLINE PLC: KEY STRATERGIES
TABLE 82. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: KEY EXECUTIVES
TABLE 83. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT
TABLE 84. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCT SEGMENTS
TABLE 85. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCT PORTFOLIO
TABLE 86. TEVA PHARMACEUTICAL INDUSTRIES LIMITED: KEY EXECUTIVES
TABLE 87. TEVA PHARMACEUTICAL INDUSTRIES LIMITED: COMPANY SNAPSHOT
TABLE 88. TEVA PHARMACEUTICAL INDUSTRIES LIMITED: PRODUCT SEGMENTS
TABLE 89. TEVA PHARMACEUTICAL INDUSTRIES LIMITED: PRODUCT PORTFOLIO
TABLE 90. AMWAY CORP.: KEY EXECUTIVES
TABLE 91. AMWAY CORP.: COMPANY SNAPSHOT
TABLE 92. AMWAY CORP.: PRODUCT SEGMENTS
TABLE 93. AMWAY CORP.: PRODUCT PORTFOLIO
TABLE 94. BAYER AG: KEY EXECUTIVES
TABLE 95. BAYER AG: COMPANY SNAPSHOT
TABLE 96. BAYER AG: PRODUCT SEGMENTS
TABLE 97. BAYER AG: PRODUCT PORTFOLIO
TABLE 98. BASF SE: KEY EXECUTIVES
TABLE 99. BASF SE: COMPANY SNAPSHOT
TABLE 100. BASF SE: PRODUCT SEGMENTS
TABLE 101. BASF SE: PRODUCT PORTFOLIO

LIST OF FIGURES
FIGURE 01. CONSUMER HEALTHCARE MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF CONSUMER HEALTHCARE MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN CONSUMER HEALTHCARE MARKET (2023-2032)
FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
FIGURE 06. MODERATE THREAT OF SUBSTITUTES
FIGURE 07. MODERATE THREAT OF NEW ENTRANTS
FIGURE 08. MODERATE INTENSITY OF RIVALRY
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALCONSUMER HEALTHCARE MARKET
FIGURE 10. CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022(%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF CONSUMER HEALTHCARE MARKET FOR OTC PHARMACEUTICALS, BY COUNTRY 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF CONSUMER HEALTHCARE MARKET FOR PERSONAL CARE PRODUCTS, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF CONSUMER HEALTHCARE MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY 2022 AND 2032(%)
FIGURE 14. CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF CONSUMER HEALTHCARE MARKET FOR ONLINE, BY COUNTRY 2022 AND 2032(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF CONSUMER HEALTHCARE MARKET FOR OFFLINE, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. CONSUMER HEALTHCARE MARKET BY REGION, 2022
FIGURE 18. U.S. CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 19. CANADA CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 20. MEXICO CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 21. GERMANY CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 22. FRANCE CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 23. UK CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 24. ITALY CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 25. SPAIN CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 26. REST OF EUROPE CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 27. CHINA CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 28. JAPAN CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 29. INDIA CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 30. AUSTRALIA CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 31. SOUTH KOREA CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 32. REST OF ASIA-PACIFIC CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 33. BRAZIL CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 34. SAUDI ARABIA CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 35. SOUTH AFRICA CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 36. REST OF LAMEA CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 37. TOP WINNING STRATEGIES, BY YEAR
FIGURE 38. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 39. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 40. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 41. COMPETITIVE DASHBOARD
FIGURE 42. COMPETITIVE HEATMAP: CONSUMER HEALTHCARE MARKET
FIGURE 43. TOP PLAYER POSITIONING, 2022
FIGURE 44. JOHNSON & JOHNSON: NET SALES, 2020-2022 ($MILLION)
FIGURE 45. JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 46. JOHNSON & JOHNSON: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 47. SANOFI S.A.: NET SALES, 2020-2022 ($MILLION)
FIGURE 48. SANOFI S.A.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 49. SANOFI S.A.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 50. PFIZER INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 51. PFIZER INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 52. PFIZER INC.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 53. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
FIGURE 54. ABBOTT LABORATORIES: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
FIGURE 55. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 56. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 57. GLAXOSMITHKLINE PLC: NET SALES, 2020-2022 ($MILLION)
FIGURE 58. GLAXOSMITHKLINE PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 59. GLAXOSMITHKLINE PLC: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 60. TEVA PHARMACEUTICAL INDUSTRIES LIMITED: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 61. TEVA PHARMACEUTICAL INDUSTRIES LIMITED: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 62. BAYER AG: NET SALES, 2020-2022 ($MILLION)
FIGURE 63. BAYER AG: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
FIGURE 64. BAYER AG: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 65. BAYER AG: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 66. BASF SE: NET SALES, 2020-2022 ($MILLION)
FIGURE 67. BASF SE: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
FIGURE 68. BASF SE: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 69. BASF SE: REVENUE SHARE BY REGION, 2022 (%)

  • Not Sure / Need Reassuring
    • Confirm Content

      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages

      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives

      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices

      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts

      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies

      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses

      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License

      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats

      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery

      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges

      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card

      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer

      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security

      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security

      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE
  • $3456.00 $3110.40
  • $5730.00 $5157.00
  • $9600.00 $8640.00
  • ADD TO BASKET
  • BUY NOW